Re: Cancer's rapacious need for iron
markd_at_toad-net.com
Date: 11/03/04
- Next message: markd_at_toad-net.com: "Re: Iron chelation / Eales' disease"
- Previous message: tcomeau: "Re: insights into pharma"
- Maybe in reply to: doe: "Cancer's rapacious need for iron"
- Next in thread: doe: "Re: Cancer's rapacious need for iron"
- Reply: doe: "Re: Cancer's rapacious need for iron"
- Messages sorted by: [ date ] [ thread ]
Date: 03 Nov 2004 17:01:39 GMT
All cells need iron to devide, iron doesn't cause cancer, iron causing all
disease thesis not supported by describing a normal process of iron:
"Cancer cells need a lot of iron to replicate DNA when they divide," Lai"
>
>Oct. 14, 2004 | Science and Tech
>UW licenses potential cancer treatment derived from ancient Chinese folk remedy
>FROM: Rob Harrill rharrill@u.washington.edu 206-543-2580
>
>A group of promising cancer-fighting compounds derived from a substance used in
>ancient Chinese medicine will be developed for potential use in humans, the
>University of Washington announced today.
>The UW TechTransfer Office has signed a licensing agreement with Chongqing
>Holley Holdings, a Chinese company, and Holley Pharmaceuticals, its U.S.
>subsidiary.
>
>The compounds, all developed through the research of UW scientists Henry Lai
>and Narendra Singh of the Department of Bioengineering and Tomikazu Sasaki of
>the Department of Chemistry, make use of a substance known as artemisinin,
>found in the wormwood plant and used throughout Asia since ancient times to
>treat malaria.
>
>Although the compounds are promising, potential medical applications are still
>years away, officials say.
>
>"We are very excited about the UW's discovery and an opportunity to develop an
>artemisinin-based cancer drug," Kevin Mak, chief scientist at Holley, said.
>"The technology is very promising, but it's in its early stages. Further
>research and clinical trials are needed."
>
>The company, located in Chongqing, China, has been in the artemisinin business
>for more than 30 years, and is a world leader in farming, extracting and
>manufacturing artemisinin, its derivatives and artemisinin-based anti-malaria
>drugs, officials say.
>
>Lai said he became interested in artemisinin about 10 years ago. The chemical
>helps control malaria because it reacts with the high iron concentrations found
>in the single-cell malaria parasite. When artemisinin comes into contact with
>iron, a chemical reaction ensues, spawning charged atoms that chemists call
>"free radicals." The free radicals attack the cell membrane and other
>molecules, breaking it apart and killing the parasite.
>
>Lai said he began to wonder if the process might work with cancer, too.
>
>"Cancer cells need a lot of iron to replicate DNA when they divide," Lai
>explained. "As a result, cancer cells have much higher iron concentrations than
>normal cells. When we began to understand how artemisinin worked, I started
>wondering if we could use that knowledge to target cancer cells."
>
>Perhaps the most promising of the methods licensed involves the use of
>transferrin, to which the researchers bind artemisinin at the molecular level.
>Transferrin is an iron-carrying protein found in blood, and is transported into
>cells via transferrin receptors on a cell's surface.
>
>Iron-hungry cancer cells typically have significantly more transferrin
>receptors on their surface than normal cells, which allows them to take in more
>of the iron-carrying protein. That, according to Lai, is what seems to make the
>compound so effective.
>
>"We call it a Trojan horse because a cancer cell recognizes transferrin as a
>natural, harmless protein and picks up the tagged compound without knowing that
>a bomb -- artemisinin -- is hidden inside."
>
>Once inside the cancer cell, the iron is released and reacts with the
>artemisinin. That makes the compound both highly toxic and, because of cancer's
>rapacious need for iron, highly selective. Surrounding, healthy cells are
>essentially undamaged.
>
>"Our research in the lab indicated that the artemisinin-tagged transferrin was
>34,000 times more effective in selecting and killing the cancer cells than
>normal cells," Lai said. "Artemisinin alone is 100 times more effective, so
>we've greatly enhanced the selectivity."
>
>###
>
>
>For more information, contact Lai at (206) 543-1071 or hlai@u.washington.edu.
>The Holley contact is Michael Liu, (714) 606-8415 or michael@holleypharma.com.
>
>
>Who loves ya.
>Tom
>Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
>Man Is A Herbivore! http://pages.ivillage.com/ironjustice/manisaherbivore
>DEAD PEOPLE WALKING http://pages.ivillage.com/ironjustice/deadpeoplewalking
- Next message: markd_at_toad-net.com: "Re: Iron chelation / Eales' disease"
- Previous message: tcomeau: "Re: insights into pharma"
- Maybe in reply to: doe: "Cancer's rapacious need for iron"
- Next in thread: doe: "Re: Cancer's rapacious need for iron"
- Reply: doe: "Re: Cancer's rapacious need for iron"
- Messages sorted by: [ date ] [ thread ]
Relevant Pages
|